GVK Group - Infrastructure, Life Sciences & Humanitarian Impact

Launched

2006 (Terminal 2 inaugurated 2013)

Objective

Transform Mumbai's Chhatrapati Shivaji Maharaj International Airport into a world-class facility integrating Indian art, culture, and architectural excellence, making it a landmark of global aviation.

Reported Outcomes

Terminal 2 recognised globally as one of the world's finest airport terminals; 5,000+ Indian artworks; Jaya He GVK New Museum - world's first airport art museum; world's best airport award for four consecutive years; Forbes India Art Award and Conde Nast Excellence Award (2014).

Launched

2001 (founded as GVK Biosciences)

Objective

Build world-class pharmaceutical contract research and development capability in India, making the country a global hub for drug discovery, development, and manufacturing services.

Reported Outcomes

Asia's leading CRDO; 2,500+ scientists; serves 15 of the world's top 20 pharmaceutical companies; fully integrated drug discovery to manufacturing services; recognised as India's leading pharmaceutical services company.

Launched

2005 (ongoing; Vice Chairman since 2009)

Objective

Build the world's most comprehensive public-private partnership emergency ambulance service, providing free life-saving emergency response to India's entire population regardless of ability to pay.

Reported Outcomes

World's largest PPP ambulance service; 108 Emergency Response Service across 15 states and 2 Union Territories; 15,000 ambulances; 60,000 trained personnel; 850 million people served free of charge; 5 million+ lives saved since inception.

Launched

2016

Objective

Build a global biopharma data and AI analytics company to accelerate drug discovery and development, drawing on proprietary technology platforms and deep pharmacology and clinical data expertise.

Reported Outcomes

500+ professionals; 90+ customers; serves 15 of top 20 global pharma companies; AI and machine learning platforms deployed for drug discovery acceleration; recognised as a leading global biopharma analytics company.

Launched

Ongoing family office investment platform

Objective

Build a globally diversified technology investment portfolio across India, USA, Africa, and South East Asia, backing disruptive founders and emerging platforms with patient capital and strategic guidance.

Reported Outcomes

25+ global startup investments; five unicorn investments: Cred, Upstox, Hive, Chipper Cash, Genies; active growth-stage portfolio including Aragen and Excelra; son G.V. Keshav Reddy leads investment operations.

Launched

2008 (Managing Director tenure 2008–2017)

Objective

Develop Kempegowda International Airport as a gateway to South India, creating world's first garden terminal integrating living green spaces, biodiversity, and natural beauty into the passenger experience.

Reported Outcomes

World's first garden terminal designed and developed; established Bengaluru as South India's premier aviation gateway; innovative green architecture concept widely recognised internationally.